ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NUTX vs V // GROSS PROFIT MARGIN

Nutex Health Inc. (NASDAQ) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: NUTX 5 — V 6
■ METRIC PARITY
gross-margins
50.80%
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NUTX VS. V) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NUTX V SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 50.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 85.00% 32.30% +52.70 NUTX /roic <GO>
EV/EBITDA & P/E Valuation 4.6x 28.9x -24.30 NUTX /valuation <GO>
Free Cash Flow Yield 17.07% 2.90% +14.17 NUTX /fcf-yield <GO>
Operating Margin 31.50% 60.00% -28.50 V /operating-margins <GO>
Net Profit Margin 8.10% 50.10% -42.00 V /net-margins <GO>
Revenue Growth (YoY) 82.40% 11.30% +71.10 NUTX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.63% -0.63 V /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.75 9.09 -5.34 V /balance-sheet <GO>
Piotroski F-Score Quality 9/9 9/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.7 65.6 -18.92 V /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.06 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 17.1x 34.0x -16.90 NUTX /forward-pe <GO>
Enterprise Scale & Market Cap $1.44B $733.53B -$732.10B V /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NUTX REV V REV NUTX GROSS % V GROSS % NUTX FCF V FCF
FY 2025 $875.3M $40.00B 50.8% — $245.6M $21.26B
FY 2024 $479.9M $35.93B 40.9% — $20.8M $18.33B
FY 2023 $247.6M $32.65B — — $1.3M $19.29B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NUTX // BETA —
V // BETA 1.06